Kymera Stock 130%: $135 Million Buy Boosts Immunology Bet
A major stake in Kymera Therapeutics highlights growing investor optimism in targeted protein degradation. This artic...
Determine which cash back credit card suits you best. Understand your spending habits to choose the right card for maximum rewards.
26,137 articlesA major stake in Kymera Therapeutics highlights growing investor optimism in targeted protein degradation. This artic...
NVIDIA will begin counting stock-based compensation in non-GAAP results from Q1 FY2027, a shift that rekindles a long...
A single Tuesday remark from a prominent political figure can ripple through the markets. This article explains what ...
JPMorgan warns that retail investors showing signs of fatigue could temper stock demand as Iran-related tensions inte...
Occidental Petroleum uses $9.7B from the OxyChem sale to trim debt, boosting cash flow and dividends. Berkshire Hatha...
In June, gold and silver prices pulled back, pressuring Hycroft Mining, a Nevada-focused, single-mine precious metals...
Broadcom is reshaping its AI compute position beyond hardware. This analysis outlines a plausible path for Broadcom's...
A routine 2026 cash-out from a CD ladder could lift Medicare premiums in 2028 due to IRMAA lookback rules. Retirees s...
In March 2026, a disciplined approach to income investing means looking for companies with a proven track record of r...
As UnitedHealth gears up for its July 16 results, traders focus on pricing power and rising cash flow as the main rea...
A major industrial player signals confidence with a $4.3 million stake move. This analysis explains what worthington ...
Jerash (JRSH) 2026 earnings could hinge on demand cycles, margin expansion, and stronger execution. This guide breaks...